Artigo de periodico

Prevalence of endometrial cancer and hyperplasia in non-symptomatic overweight and obese women (2008)

• Authors:
  • Viola, Alexandre S.
  • Gouveia, Daniela
  • Andrade, Liliana
  • Aldrighi, José Mendes
  • Viola, Carolina F. M.
  • Bahamondes, Luis
• Autor USP: ALDRIGHI, JOSE MENDES - FSP
• Unidade: FSP
• DOI: 10.1111/j.1479-828x.2008.00845.x
• Subjects: NEOPLASIAS; ENDOMÉTRIO; HIPERPLASIAS; OBESIDADE; PESOS E MEDIDAS CORPORAIS
• Language: Inglês
• Abstract: Background: Obesity is a public health problem and it is necessary to identify if non-symptomatic obese women must be submitted to endometrial evaluation. Aims: To determine the prevalence of endometrial hyperplasia and cancer in non-symptomatic overweight or obese women. Methods: A cross-sectional study was carried out in 193 women submitted to an endometrial biopsy using a Pipelle de Cornier. The findings were classified as normal, hyperplasia or cancer, and the results were compared to body mass index (BMI; kg/m2). For the purpose of statistical analysis, women were divided into two groups: women of reproductive age and postmenopausal women, and according to BMI as overweight or obese. Results: The prevalence of endometrial cancer and hyperplasia was 1.0% and 5.8% in women of reproductive age and 3.0% and 12.1% in postmenopausal women, respectively. According to logistic regression, being in the postmenopause increased the risk of endometrial hyperplasia and cancer to 1.19 (95% confidence interval (CI): 0.36-3.90), while being postmenopausal and severely obese increased the odds ratio (OR) to 1.58 (95%CI: 0.30-8.23) and being postmenopausal and morbidly obese increased the OR to 2.72 (95%CI: 0.65-11.5). No increase in risk was found in women of reproductive age who were either overweight or obese. Discussion: Our results show that non-symptomatic, severe or morbidly obese postmenopausal women have a high risk of developing endometrial hyperplasia or cancer;however, no such risk was found for women of reproductive age.
• Imprenta:
  • Publisher place: Melbourne
  • Date published: 2008
• Source:
  • Título do periódico: The Australian and New Zealand Journal of Obstetrics and Gynaecology
  • ISSN: 0004-8666
  • Volume/Número/Paginação/Ano: v. 48, n. 2, p. 207-213, Apr. 2008

Informações sobre o DOI: 10.1111/j.1479-828x.2008.00845.x (Fonte: oaDOI API)
• Este periódico é de assinatura
• Este artigo NÃO é de acesso aberto
  
• Cor do Acesso Aberto: closed

---

How to cite

A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

• ABNT

  VIOLA, Alexandre S. et al. Prevalence of endometrial cancer and hyperplasia in non-symptomatic overweight and obese women. The Australian and New Zealand Journal of Obstetrics and Gynaecology, v. 48, n. 2, p. 207-213, 2008Tradução . . Disponível em: https://doi.org/10.1111/j.1479-828x.2008.00845.x. Acesso em: 24 set. 2024.

• APA

  Viola, A. S., Gouveia, D., Andrade, L., Aldrighi, J. M., Viola, C. F. M., & Bahamondes, L. (2008). Prevalence of endometrial cancer and hyperplasia in non-symptomatic overweight and obese women. The Australian and New Zealand Journal of Obstetrics and Gynaecology, 48( 2), 207-213. doi:10.1111/j.1479-828x.2008.00845.x

• NLM

  Viola AS, Gouveia D, Andrade L, Aldrighi JM, Viola CFM, Bahamondes L. Prevalence of endometrial cancer and hyperplasia in non-symptomatic overweight and obese women [Internet]. The Australian and New Zealand Journal of Obstetrics and Gynaecology. 2008 ; 48( 2): 207-213.[citado 2024 set. 24 ] Available from: https://doi.org/10.1111/j.1479-828x.2008.00845.x

• Vancouver

  Viola AS, Gouveia D, Andrade L, Aldrighi JM, Viola CFM, Bahamondes L. Prevalence of endometrial cancer and hyperplasia in non-symptomatic overweight and obese women [Internet]. The Australian and New Zealand Journal of Obstetrics and Gynaecology. 2008 ; 48( 2): 207-213.[citado 2024 set. 24 ] Available from: https://doi.org/10.1111/j.1479-828x.2008.00845.x

Últimas obras dos mesmos autores vinculados com a USP cadastradas na BDPI:

• Comparison between raloxifene and hormone replacement therapy on ambulatory blood pressure and arterial stiffness
• Efeitos da terapêutica de reposição hormonal transdérmica combinada e do raloxifeno sobre a proteína C reativa e anticorpos anti-LDL oxidada
• Efeito da terapia de reposição hormonal na complacência vascular em mulheres na pós-menopausa
• Qualidade do sono em mulheres paulistanas no climatério
• Epidemiologia e fatores de risco da doença cardiovascular após a menopausa
• Effects of hormone replacement therapy or raloxifene on ambulatory blood pressures and arterial stoffness in treated hypertensive postmenopausal women
• Papel da terapia da reposição hormonal I: lípide, glicose, distribuição da gordura corpórea e endotélio
• Epidemiologia das doenças cardiovasculares nas mulheres
• Estado atual da terapêutica hormonal na peri e na pós-menopausa
• Efeitos do raloxifeno comparado a terapêutica de reposição hormonal contendo estradiol associado a progestógeno sobre a complacência vascular, em mulheres idosas com hipertensão arterial sistêmica